Literature DB >> 3597448

Modification of the ELISA for the estimation of tetanus antitoxin in human sera.

O Simonsen, C Schou, I Heron.   

Abstract

The use of indirect ELISA for the quantitation of tetanus toxin neutralizing antibodies in human sera is limited by marked overestimations in low titered sera. The reasons for the discrepancy between the results obtained by ELISA and by in vivo assay and modifications of the ELISA to overcome the problem were investigated. Catching ELISA and indirect ELISA using trays coated with the contaminant proteins in toxoid preparations indicated that antibodies to contaminants were only partly responsible for the discrepancy and the introduction of these modifications did not solve the problem. In ELISA competition experiments with toxin neutralizing monoclonal antibodies, the human immunoglobulins irrelevant in toxin neutralization, but detectable in indirect ELISA, were found to be difficult to inhibit in their binding to the solid antigen phase. These might represent antitoxins bound bivalently to the solid phase but with affinities in monovalent binding insufficient for toxin neutralization or other coupled antibodies due to conformational changes of the antigen. A competition ELISA with toxin in solution was therefore developed to assess selectively the antitoxin capable of binding the antigen in solution and by this approach the in vivo activities of even low titered sera were accurately predicted. This antigen competition ELISA may be easily introduced into routine tetanus serology and the principle may also be of value for the in vitro detection of functional antibodies to other antigens.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3597448     DOI: 10.1016/0092-1157(87)90037-0

Source DB:  PubMed          Journal:  J Biol Stand        ISSN: 0092-1157


  9 in total

1.  Health status of the Pakistani population: a health profile and comparison with the United States.

Authors:  G Pappas; T Akhtar; P J Gergen; W C Hadden; A Q Khan
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

2.  Influence of prevaccination immunity on the human B-lymphocyte response to a Haemophilus influenzae type b conjugate vaccine.

Authors:  T Barington; K Kristensen; J Henrichsen; C Heilmann
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

3.  Tetanus Immunity among Women Aged 15 to 39 Years in Cambodia: a National Population-Based Serosurvey, 2012.

Authors:  Heather M Scobie; Bunsoth Mao; Sokhal Buth; Kathleen A Wannemuehler; Charlotte Sørensen; Chheng Kannarath; M Harley Jenks; Delynn M Moss; Jeffrey W Priest; Sann Chan Soeung; Michael S Deming; Patrick J Lammie; Christopher J Gregory
Journal:  Clin Vaccine Immunol       Date:  2016-07-05

Review 4.  Factors affecting the immunogenicity and potency of tetanus toxoid: implications for the elimination of neonatal and non-neonatal tetanus as public health problems.

Authors:  V Dietz; A Galazka; F van Loon; S Cochi
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

5.  Pneumococcal conjugate vaccine followed by pneumococcal polysaccharide vaccine; immunogenicity in patients with ataxia-telangiectasia.

Authors:  A Stray-Pedersen; I S Aaberge; A Früh; T G Abrahamsen
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

6.  The impact of an early truncating founder ATM mutation on immunoglobulins, specific antibodies and lymphocyte populations in ataxia-telangiectasia patients and their parents.

Authors:  A Stray-Pedersen; T Jónsson; A Heiberg; C R Lindman; E Widing; I S Aaberge; A L Borresen-Dale; T G Abrahamsen
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

7.  Neonatal tetanus in Peru: risk assessment with modified enzyme-linked immunosorbent assay and toxoid skin test.

Authors:  L Vernacchio; G Madico; M Verastegui; F Diaz; T S Collins; R H Gilman
Journal:  Am J Public Health       Date:  1993-12       Impact factor: 9.308

8.  Chronic mucocutaneous candidiasis and primary hypothyroidism in two families.

Authors:  Anne Grethe Myhre; Asbjørg Stray-Pedersen; Steinar Spangen; Eigill Eide; Dag Veimo; Per Morten Knappskog; Tore G Abrahamsen; Eystein S Husebye
Journal:  Eur J Pediatr       Date:  2004-10       Impact factor: 3.183

9.  Mucosal immune responses and protection against tetanus toxin after intranasal immunization with recombinant Lactobacillus plantarum.

Authors:  C Grangette; H Müller-Alouf; D Goudercourt; M C Geoffroy; M Turneer; A Mercenier
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.